[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369156-105":59,"doc-detail-369156-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-and-validation-of-a-prognostic-signature-of-drug-resistance-and-mitochondrial-energy-metabolism-related-differentially-expressed-genes-for-breast-cancer","Identification and validation of a prognostic signature of drug resistance and mitochondrial energy metabolism-related differentially expressed genes for breast cancer","","Drug resistance drives poor prognosis in breast cancer, and cancer cells remain dependent on mitochondrial functions for DNA synthesis, suggesting a link between mitochondrial energy metabolism and drug resistance. This study evaluates mitochondrial energy metabolism- and drug resistance-related differentially expressed genes (DMRDEGs) as biomarkers or targets. Genes were integrated from DRESIS, MSigDB, GeneCards, and TCGA-BRCA/GEO to derive DMRDEGs, cluster patients, and build a prognostic model using Cox, LASSO, and Random Forest. Immune infiltration and tumor mutation burden were assessed across risk groups. In vitro assays and oxygen consumption measurements supported AIFM1 roles in proliferation, migration, invasiveness, and drug resistance. DMRDEGs predicted outcomes and AIFM1 emerged as a therapeutic candidate.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-and-validation-of-a-prognostic-signature-of-drug-resistance-and-mitochondrial-energy-metabolism-related-differentially-expressed-genes-for-breast-cancer/369156/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-and-validation-of-a-prognostic-signature-of-drug-resistance-and-mitochondrial-energy-metabolism-related-differentially-expressed-genes-for-breast-cancer/369156.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about breast cancer?","Question",{"text":112,"@type":113},"The study investigates whether genes related to drug resistance and mitochondrial energy metabolism can serve as diagnostic and prognostic biomarkers or therapeutic targets in breast cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were drug resistance and mitochondrial energy metabolism-related genes identified and combined?",{"text":117,"@type":113},"Genes related to drug resistance were obtained from the DRESIS database and MSigDB, while mitochondrial energy metabolism genes were collected from GeneCards and existing literature, then merged with differentially expressed genes from TCGA-BRCA and GEO.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the prognostic model relate to immune features and tumor biology?",{"text":121,"@type":113},"Patients were separated into high- and low-risk groups using unsupervised consensus clustering based on DMRDEGs, and immune infiltration and tumor mutation burden differences were examined between these groups.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369156,1790217951,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Xu etal. Journal of Translational Medicine (2025) 23:131  \n[https://doi.org/10.1186/s12967-025-06080-7](https://doi.org/10.1186/s12967-025-06080-7)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nIdentification and validation of a prognostic   signature of drug resistance and mitochondrial energy metabolism-related differentially expressed genes for breast cancer  \nTiankai Xu1†, Chu Chu1†, Shuyu Xue1†, Tongchao Jiang1, Ying Wang1, Wen Xia2 and Huanxin Lin 1*  \nAbstract  \nBackground Drug resistance constitutes one of the principal causes of poor prognosis in breast cancer patients. Although cancer cells can maintain viability independently of mitochondrial energy metabolism, they remain reliant on mitochondrial functions for the synthesis of new DNA strands. This dependency underscores a potential link between mitochondrial energy metabolism and drug resistance. Hence, drug resistance and mitochondrial energy metabolism-related differentially expressed genes (DMRDEGs) may emerge as candidates for novel cancer biomarkers. This study endeavors to assess the viability of DMRDEGs as biomarkers or therapeutic targets for breast cancer. Methods We utilized the DRESIS database and MSigDB to identify genes related to drug resistance. Additionally, we sourced genes associated with mitochondrial energy metabolism from GeneCards and extant literature. By merging these genes with differentially expressed genes observed in normal and tumor tissues from theTCGA-BRCA and GEO databases, we successfully identified the DMRDEGs. Employing unsupervised consensus clustering, we divided breast cancer patients into two distinct groups based on the DMRDEGs. Consequently, we identified four hub genes to formulate a prognostic model, applying Cox regression, LASSO regression, and Random Forest methods. Furthermore, we examined immune infiltration and tumor mutation burden of the genes within our model and scrutinized divergences in the immune microenvironment between high-and low-risk groups. Small hairpin RNA and lentiviral plasmids were designed for stable transfection of breast cancer cell lines MDA-MB-231 and HCC1806 . By conducting clone formation, scratch test, transwell assays, cell viability assay and measurement of oxygen consumption we initiated a preliminary investigation into mechanistic roles of AIFM1 .  \nResults We utilized DMRDEGs to develop a prognostic model that includes four mRNAs for breast cancer. This model combined with various clinical features and critical breast cancer facets, demonstrated remarkable efficacy in predicting patient outcomes. AIFM1 appeared to enhance the proliferation, migration, and invasiveness of breast cancer cell lines MDA-MB-231 and HCC1806 . Moreover, by reducing oxygen consumption, it aids in the cancer cells’ acquisition of drug resistance.  \n†Tiankai Xu, Chu Chu and Shuyu Xue have contributed equally to this work.  \n*Correspondence: Huanxin Lin [linhx@sysucc.org.cn](linhx@sysucc.org.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyrigh","cbCaip8rRRxfZ2Ni","https://ap.wps.com/l/cbCaip8rRRxfZ2Ni","pdf",20926462,27,"English","# Background\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What question does the study address about breast cancer?\",\"answer\":\"The study investigates whether genes related to drug resistance and mitochondrial energy metabolism can serve as diagnostic and prognostic biomarkers or therapeutic targets in breast cancer patients.\"},{\"question\":\"How were drug resistance and mitochondrial energy metabolism-related genes identified and combined?\",\"answer\":\"Genes related to drug resistance were obtained from the DRESIS database and MSigDB, while mitochondrial energy metabolism genes were collected from GeneCards and existing literature, then merged with differentially expressed genes from TCGA-BRCA and GEO.\"},{\"question\":\"How does the prognostic model relate to immune features and tumor biology?\",\"answer\":\"Patients were separated into high- and low-risk groups using unsupervised consensus clustering based on DMRDEGs, and immune infiltration and tumor mutation burden differences were examined between these groups.\"}]","Identification and validation of a prognostic signature of drug resistance and mitochondrial energy metabolism-related differentially expressed genes for breast cancer | PDF",1790181070,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9153cc567a1cc789b43d8139807a3cea.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/422145c126a9279d51b5540867a1d330.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f62b7f859784eeaade0b43738250f3e3.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13a4f8ad479f053fbe1a2143edd2435d.webp",980,1301]